Evidence map›Paper›PMID 35054967›Full record

ArticleInternational journal of molecular sciences2022

Effect of 1-Ethyl-3-methylimidazolium Tetrafluoroborate and Acetate Ionic Liquids on Stability and Amyloid Aggregation of Lysozyme.

Diana Fedunova, Andrea Antosova, Jozef Marek, Vladimir Vanik, Erna Demjen, Zuzana Bednarikova, Zuzana Gazova

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Amyloid Formation in Nanoliter Droplets.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Diana FedunovaInstitute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.ORCID 0000-0001-5419-2894
Andrea AntosovaInstitute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.
Jozef MarekInstitute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.
Vladimir VanikInstitute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.
Erna DemjenInstitute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.
Zuzana BednarikovaInstitute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.ORCID 0000-0003-0837-9564
Zuzana GazovaInstitute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia.

Funding

Slovak grant agency VEGA 2/0030/18
6 · The paper itself

Abstract

Amyloid fibrils draw attention as potential novel biomaterials due to their high stability, strength, elasticity or resistance against degradation. Therefore, the controlled and fast fibrillization process is of great interest, which raises the demand for effective tools capable of regulating amyloid fibrillization. Ionic liquids (ILs) were identified as effective modulators of amyloid aggregation. The present work is focused on the study of the effect of 1-ethyl-3-methyl imidazolium-based ILs with kosmotropic anion acetate (EMIM-ac) and chaotropic cation tetrafluoroborate (EMIM-BF

Indexed as

Protein AggregatesAcetatesAmyloidAmyloidogenic ProteinsHydrophobic and Hydrophilic InteractionsImidazolesIonic LiquidsKineticsModels, MolecularMuramidaseProtein ConformationProtein StabilitySolventsTemperatureThermodynamics1-ethyl-3-methylimidazolium tetrafluoroborateAcetatesAmyloidAmyloidogenic ProteinsImidazolesIonic LiquidsMuramidaseProtein AggregatesSolventsamyloid aggregationamyloid fibril polymorphismionic liquidsprotein stability

Identifiers

PMID35054967
PMCPMC8775716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.